SPECIFIC AND OPTIMAL THERAPY FOR GBM LEVERAGED FROM THE IVY GBM PROJECT TO IMPACT THE DESIGN OF CLINICAL TRIALS FOR GBM PATIENTS.

PI and Consortium Leader: Michael Berens, Ph.D.
Deputy Director, Research Resources
Translational Genomics Research Institute (TGen)